GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Mountain Crest Acquisition Corp II (NAS:MCADU) » Definitions » ROE % Adjusted to Book Value

Mountain Crest Acquisition II (Mountain Crest Acquisition II) ROE % Adjusted to Book Value : 0.00% (As of Oct. 2020)


View and export this data going back to 2021. Start your Free Trial

What is Mountain Crest Acquisition II ROE % Adjusted to Book Value?

Mountain Crest Acquisition II's ROE % for the quarter that ended in Oct. 2020 was -4.17%. Mountain Crest Acquisition II's PB Ratio for the quarter that ended in Oct. 2020 was N/A. Mountain Crest Acquisition II's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2020 was N/A.


Mountain Crest Acquisition II ROE % Adjusted to Book Value Historical Data

The historical data trend for Mountain Crest Acquisition II's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Crest Acquisition II ROE % Adjusted to Book Value Chart

Mountain Crest Acquisition II Annual Data
Trend Dec20
ROE % Adjusted to Book Value
-

Mountain Crest Acquisition II Semi-Annual Data
Oct20
ROE % Adjusted to Book Value -

Competitive Comparison of Mountain Crest Acquisition II's ROE % Adjusted to Book Value

For the Shell Companies subindustry, Mountain Crest Acquisition II's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mountain Crest Acquisition II's ROE % Adjusted to Book Value Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Mountain Crest Acquisition II's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Mountain Crest Acquisition II's ROE % Adjusted to Book Value falls into.



Mountain Crest Acquisition II ROE % Adjusted to Book Value Calculation

Mountain Crest Acquisition II's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Mountain Crest Acquisition II's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-4.17% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Crest Acquisition II ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Mountain Crest Acquisition II's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Mountain Crest Acquisition II (Mountain Crest Acquisition II) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
311 West 43rd Street, 12th Floor, New York, NY, USA, 10036
Website
Mountain Crest Acquisition Corp II is a blank check company.
Executives
Frank Karbe director, officer: See Remarks C/O MYOVANT SCIENCES INC., 2000 SIERRA POINT PARKWAY, 9TH FLOOR, BRISBANE CA 94005
Elder Granger director 5176 S. LEWISTON WAY, CENTENNIAL CO 80015
Richard H Carmona director 1221 BROADWAY, OAKLAND CA 94612
Geoffrey M. Parker director 15 RIORDAN PLACE, MENLO PARK CA 94025
Risa J Lavizzo-mourey director GE HEALTHCARE TECHNOLOGIES INC., 500 W. MONROE ST., CHICAGO IL 60661
Andrew J. Armanino director C/O CALIFORNIA BANCORP, 1300 CLAY STREET, FIFTH FLOOR, OAKLAND CA 94612
David P Perry director, 10 percent owner, officer: See Remarks 1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303
Suying Liu director 311 WEST 43RD STREET, 12TH FLOOR, NEW YORK NY 10036
Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended 10 percent owner 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
David P. Perry 2015 Trust 10 percent owner 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Mark A. Berman officer: Chief Medical Officer 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kevin J Appelbaum director, 10 percent owner, officer: Chief Executive Officer 4160 DUBLIN BLVD., SUITE 200, DUBLIN CA 94568
Mark Heinen officer: See Remarks 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Justin Zamirowski officer: Chief Commercial Officer 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104
Kristin Wynholds officer: Chief Product Officer 548 MARKET STREET, #49404, SAN FRANCISCO CA 94104

Mountain Crest Acquisition II (Mountain Crest Acquisition II) Headlines

From GuruFocus

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

By Business Wire Business Wire 10-29-2021